AD-2281
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 05, 2025
A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282
(clinicaltrials.gov)
- P1 | N=60 | Not yet recruiting | Sponsor: Addpharma Inc.
New P1 trial • Dyslipidemia
1 to 1
Of
1
Go to page
1